Cost in the Use of Enoxaparin Compared With Unfractionated Heparin in Patients With Atrial Fibrillation Undergoing a Transesophageal Echocardiography-Guided Cardioversion (from Assessment of Cardioversion Using Transesophageal Echocardiography [ACUTE] II Randomized Multicenter Study)

American Journal of Cardiology

Volumn 101, Issue 3, 2008, Pages 338-342

  Zhao, Liping ^a   Zhang, Zefeng ^a,b   Kolm, Paul ^c   Jasper, Susan ^d   Lewis, Cheryl ^a   Klein, Allan ^d   Weintraub, William ^c  

^a EMORY UNIVERSITY   (United States)

^b NANTONG UNIVERSITY   (China)

^c CHRISTIANA CARE HEALTH SYSTEM   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; BOOTSTRAPPING; CARDIOVERSION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG USE; EMERGENCY WARD; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HOSPITAL BILLING; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTPATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; COSTS AND COST ANALYSIS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; ENOXAPARIN; FEMALE; FIBRINOLYTIC AGENTS; HEALTH SERVICES; HEPARIN; HOSPITAL COSTS; HUMANS; MALE; MEDICARE; MIDDLE AGED; RESEARCH DESIGN; ULTRASONOGRAPHY, INTERVENTIONAL; UNITED STATES;

EID: 38549093225     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.09.075     Document Type: Article

References (12)

1. Klein A.L., Jasper S.E., Katz W.E., Malouf J.F., Pape L.A., Stoddard M.F., Apperson-Hansen C., and Lieber E.A. The use of enoxaparin compared to unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transesophageal echocardiography-guided cardioversion: Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Randomized Multicenter Study. Eur Heart J 27 (2006) 2858-2865
2. Murray R.D., Shah A., Jasper S.E., Goodman A., Deitcher S.R., Katz W.E., Malouf J.F., Stoddard M.F., Grimm R.A., and Klein A.L. Transesophageal echocardiography guided enoxaparin antithrombotic strategy for cardioversion of atrial fibrillation: the ACUTE II pilot study. Am Heart J 139 (2000) 1-7
3. Becker E.R. Physician costs US: conceptual and methodological issues and selected applications. In: Weintraub W.S. (Ed). Cardiovascular Economics (2004), Human Press, Totowa, NJ 45-62
4. Centers for Medicare and Medicaid Services. http://www.cms.hhs.gov/MedicareFeeforSvcPartsAB/Downloads/DRG04.pdf Accessed August 22, 2007.
5. Mitchell J., Burge R.T., Lee A.J., and McCall N.T. Per Case Prospective Payment for Episodes of Hospital Care (1995), US Department of Commerce National Technical Information Service, Springfield, VA Publication PB95226023
6. Centers for Medicare and Medicaid Services. http://www.cms.hhs.gov/apps/ama/license.asp?file=/MedicareFeeforSvcPartsAB/Downloads/LEVEL1CHARG04.pdf Accessed August 22,2004
7. Red Book 2004 Drug Topics (2004), Thomson PDR, Montvale, NJ
8. Aujesky D., Smith K.J., Cornuz J., and Roberts M.S. Cost-effectiveness of low-molecular-weight-heparin for treatment of pulmonary embolism. Chest 128 (2005) 1601-1610
9. Efron B., and Tibshirani R.J. An Introduction to the Bootstrap (1993), Chapman & Hall, New York, NY
10. Gronefeld G., Ehrlich J.R., and Honloser S.H. Comparison of outpatient vs inpatient direct current cardioversion of atrial fibrillation: safety, efficacy and cost savings. Eur Heart J 5 suppl H (2003) H19-H24
11. Stellbrink C., Nixdorff U., Hofmann T., Lehmacher W., Daniel W.G., Hanrath P., Geller C., Mügge A., Sehnert W., Schmidt-Lucke C., and Schmidt-Lucke J.A. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Circulation 109 (2004) 997-1003
12. Klein A.L., Murray R.D., Becker E.R., Culler S.D., Weintraub W.S., Jasper S.E., Lieber E.A., Apperson-Hansen C., Heerey A.M., and Grimm R.A. Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: the ACUTE economic data at eight weeks. J Am Coll Cardiol 43 (2004) 1217-1224